Podocytes are highly specialized cells that play a central role in the physiology and pathology of the kidney glomerulus. Podocytes consist of cell body, major processes and foot processes. Podocyte foot processes contain a complete actin-based contractile apparatus. Synaptopodin is a proline-rich, actin-associated protein of podocyte foot processes and telencephalic dendrites without significant homology to any known protein. In brain and kidney, in vivo and in vitro, synaptopodin gene expression is differentiation-dependent; in podocytes, synaptopodin expression coincides with growth arrest and process formation. The C-terminal half of synaptopodin associates with actin filaments and shows about 45 percent homology with myopodin, the second gene family member that we have cloned from skeletal and heart muscle. Myopodin colocalizes with a-actinin at the Zdisc of skeletal and heart muscle sarcomer. Similarly, synaptopodin colocalizes with a-actinin cultured podocytes and in transfected NIH3T3 fibroblasts. Therefore synaptopodin may be involved in the organization or regifiation of a Z-disc equivalent in podocytes. Mice lacking synaptopodin are viable and do not show an overt phenotype in a mixed 1 29/C57 background. However they show a down regulation of paxillin and a-actinin in podocytes and desmin, an early marker of podocyte injury, is induced in podocytes of synpo-/- mice. Moreover, the adaptation of synaptopodin deficient mice to glomerular stress is reduced resulting in increased levels of proteinuria and albuminuria. Based upon these findings we hypothesize that synaptopodin functions as a key protein in the organization/regulation of the podocyte foot processes actin cytoskeleton and in modulating the severity or progression of glomerular disease. To test this hypothesis, I propose the following three Specific Aims: 1.Elucidate the functional roles of synaptopodin in podocytes in the animal. 2. Generate synaptopodin-deficient podocyte cell lines and test whether the lack of synaptopodin affects the structure, the adhesive properties and the mechanical stability of these cells. 3. Identify and characterize functional domains of synaptopodin and interacting proteins. These studies should reveal whether synaptopodin functions in stabilization of the actin cytoskeleton and in providing podocyte resistance to strain and whether synpo-!- mice may be prone to the development of glomerular injury.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK057683-01A1
Application #
6285754
Study Section
Pathology A Study Section (PTHA)
Program Officer
Scherbenske, M James
Project Start
2001-03-01
Project End
2006-02-28
Budget Start
2001-03-01
Budget End
2002-02-28
Support Year
1
Fiscal Year
2001
Total Cost
$268,000
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Christov, Marta; Clark, Abbe R; Corbin, Braden et al. (2018) Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities. JCI Insight 3:
Buvall, Lisa; Wallentin, Hanna; Sieber, Jonas et al. (2017) Synaptopodin Is a Coincidence Detector of Tyrosine versus Serine/Threonine Phosphorylation for the Modulation of Rho Protein Crosstalk in Podocytes. J Am Soc Nephrol 28:837-851
Gipson, Deb (2016) Clinical Trials in FSGS: Past Challenges and New Trial Designs. Semin Nephrol 36:453-459
Greka, Anna (2016) Human genetics of nephrotic syndrome and the quest for precision medicine. Curr Opin Nephrol Hypertens 25:138-43
Mundel, Peter (2016) Podocyte-Targeted Treatment for Proteinuric Kidney Disease. Semin Nephrol 36:459-462
Weins, Astrid; Wong, Jenny S; Basgen, John M et al. (2015) Dendrin ablation prolongs life span by delaying kidney failure. Am J Pathol 185:2143-57
Yoon, Kyoung Wan; Byun, Sanguine; Kwon, Eunjeong et al. (2015) Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53. Science 349:1261669
Mundel, Peter; Greka, Anna (2015) Developing therapeutic 'arrows' with the precision of William Tell: the time has come for targeted therapies in kidney disease. Curr Opin Nephrol Hypertens 24:388-92
Kampe, Kapil; Sieber, Jonas; Orellana, Jana Marina et al. (2014) Susceptibility of podocytes to palmitic acid is regulated by fatty acid oxidation and inversely depends on acetyl-CoA carboxylases 1 and 2. Am J Physiol Renal Physiol 306:F401-9
Balbas, Minna D; Burgess, Michael R; Murali, Rajmohan et al. (2014) MAGI-2 scaffold protein is critical for kidney barrier function. Proc Natl Acad Sci U S A 111:14876-81

Showing the most recent 10 out of 50 publications